» Articles » PMID: 38483753

CHL-DTI: A Novel High-Low Order Information Convergence Framework for Effective Drug-Target Interaction Prediction

Overview
Journal Interdiscip Sci
Specialty Biology
Date 2024 Mar 14
PMID 38483753
Authors
Affiliations
Soon will be listed here.
Abstract

Recognizing drug-target interactions (DTI) stands as a pivotal element in the expansive field of drug discovery. Traditional biological wet experiments, although valuable, are time-consuming and costly as methods. Recently, computational methods grounded in network learning have demonstrated great advantages by effective topological feature extraction and attracted extensive research attention. However, most existing network-based learning methods only consider the low-order binary correlation between individual drug and target, neglecting the potential higher-order correlation information derived from multiple drugs and targets. High-order information, as an essential component, exhibits complementarity with low-order information. Hence, the incorporation of higher-order associations between drugs and targets, while adequately integrating them with the existing lower-order information, could potentially yield substantial breakthroughs in predicting drug-target interactions. We propose a novel dual channels network-based learning model CHL-DTI that converges high-order information from hypergraphs and low-order information from ordinary graph for drug-target interaction prediction. The convergence of high-low order information in CHL-DTI is manifested in two key aspects. First, during the feature extraction stage, the model integrates both high-level semantic information and low-level topological information by combining hypergraphs and ordinary graph. Second, CHL-DTI fully fuse the innovative introduced drug-protein pairs (DPP) hypergraph network structure with ordinary topological network structure information. Extensive experimentation conducted on three public datasets showcases the superior performance of CHL-DTI in DTI prediction tasks when compared to SOTA methods. The source code of CHL-DTI is available at https://github.com/UPCLyy/CHL-DTI .

References
1.
Yang F, Zhang Q, Ji X, Zhang Y, Li W, Peng S . Machine Learning Applications in Drug Repurposing. Interdiscip Sci. 2022; 14(1):15-21. PMC: 8783773. DOI: 10.1007/s12539-021-00487-8. View

2.
Kale M, Shamkuwar P, Mourya V, Deshpande A, Shelke P . Drug Repositioning: A Unique Approach to Refurbish Drug Discovery. Curr Drug Discov Technol. 2021; 19(1):e140122192307. DOI: 10.2174/1570163818666210316114331. View

3.
Ye Q, Hsieh C, Yang Z, Kang Y, Chen J, Cao D . A unified drug-target interaction prediction framework based on knowledge graph and recommendation system. Nat Commun. 2021; 12(1):6775. PMC: 8635420. DOI: 10.1038/s41467-021-27137-3. View

4.
Lee H, Lee J . Target identification for biologically active small molecules using chemical biology approaches. Arch Pharm Res. 2016; 39(9):1193-201. DOI: 10.1007/s12272-016-0791-z. View

5.
Schirle M, Jenkins J . Identifying compound efficacy targets in phenotypic drug discovery. Drug Discov Today. 2015; 21(1):82-89. DOI: 10.1016/j.drudis.2015.08.001. View